Bio
Professor Jack Tuszyński obtained his Ph.D. in condensed matter physics in 1983 from the University of Calgary. From 1983 to 1988 he was a faculty member at the Department of Physics of the Memorial University of Newfoundland. He moved to the University of Alberta in 1988 as an assistant professor, between 1990 to 1993 he was an associate and then full professor at the Department of Physics until now. Between 2005 and 2020 he held the prestigious Allard Chair in Experimental Oncology at the Cross Cancer Institute. He was also a Fellow of the National Institute for Nanotechnology of Canada. Dr. Tuszyński held visiting professorship and research positions in China, Germany, France, Israel, Denmark, Belgium and Switzerland. He has published over 500 peer-reviewed journal papers, and 12 books. He delivered almost 400 scientific talks at conferences on five continents, half of which were invited presentations. He submitted 21 patent applications and obtained 4 patents in the USA, South Korea, Japan and Singapore. His research has been supported by over 100 research grants from Canadian, US and European funding agencies. He is on the editorial board of almost 30 international journals including the Journal of Biological Physics. He is an Associate Editor of The Frontiers Collection at Springer-Verlag, Heidelberg. The major thrust of his computational biophysics group is in silico drug design for cancer chemotherapy applications.
